Autopsy report · NCT05256875

An Analysis to Assess Non-adherence in People With Type 2 Diabetes

“The funder and the study team have mutually agreed to terminate the study considering the difficulties encountered in recruitment and consequently the impossibility to perform the planned analysis.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 6 months before it started.
• Ran for about 2 years 10 months before it stopped.
• 90 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

University of Leicester

Sponsor type

University, hospital or other

Conditions

Diabetes Mellitus, Type 2; Hypertension; Medication Adherence

Interventions

chemical adherence test, medication adherence questionnaire, pharmacy refill rate

Participants

90

Sites

2

Countries

United Kingdom

Trials that died the same way

• A Safety Study of PF-08046045/SGN-35T in Adults With Advanced Cancers
  “Study terminated as part of strategic considerations” (71% match in meaning)
• A Trial to Evaluate the Efficacy and Safety of PQ912 in Patients With Early AD
  “It has been made the strategic decision to terminate the study. This decision to terminate the study early is not being made for safety reasons.” (70% match in meaning)
• LCAR-T2C CAR-T Cells in Relapsed or Refractory CD4+ T Lymphocyte Tumor
  “Both the sponsors and collaborator are considering terminating the study” (70% match in meaning)
• Intracoronary Bolus Only Compared With Intravenous Bolus and 12-hours Infusion of Abciximab in Non-ST Elevation Myocardial Infarction.
  “The study was terminated early due to a shortage of research and analytical personnel, which prevented the completion of the study as planned” (68% match in meaning)
• Exploratory Study of Norepinephrine to Prevent Alopecia in Head and Neck Cancer Patients Treated With Radiotherapy
  “Study site has terminated the study due to the complexity of the study” (67% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.